CN1349803A - Medicine for treating diabetes and coronary heart disease - Google Patents
Medicine for treating diabetes and coronary heart disease Download PDFInfo
- Publication number
- CN1349803A CN1349803A CN 00123116 CN00123116A CN1349803A CN 1349803 A CN1349803 A CN 1349803A CN 00123116 CN00123116 CN 00123116 CN 00123116 A CN00123116 A CN 00123116A CN 1349803 A CN1349803 A CN 1349803A
- Authority
- CN
- China
- Prior art keywords
- medicine
- heart disease
- coronary heart
- radix
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The Chinese medicine for curing diabetes and its complicated coronary heart disease is made up by using the Chinese medicinal amterials of lycium berry, schisandra berry, salvia root, ginseng and ophiopogon tuber through the processes of cleaning, drying, sterilizing, pulverizing, uniformly mixing them, secondary sterilizing and packaging to obtain said finished product. It can be matched with sugar-reducing pill for taking together, and can obtain good effect.
Description
The present invention relates to the medicine of diabetic complication, definite a kind of medicine for the treatment of diabetes and coronary heart disease of saying so.
Diabetes Chang Bingfa coronary heart disease is meant in the diabetes process, owing to continue high pressure conditions and disorders of lipid metabolism, and coronary artery etc., big or middle arteries and veins takes place atherosis, and capillary basement membrane thickens and the coronary heart disease that causes.Primary disease is clinical more common, and the sickness rate of diabetes and coronary heart disease is 19.2%-38% according to statistics.Primary disease is the sickness rate height not only, and is difficult to control, normal threat to life.The treatment of primary disease, general many with blood sugar lowering, blood fat reducing, coronary artery dilating circulation are main.Western medicine is often bigger to the side effect of diabetes, and medication is careless, often can cause adverse consequences.For example: the Western medicine nitroglycerin side effect of treatment angina pectoris is giddy, distending pain in the head, flushing, cardiopalmus, occasionally untoward reaction such as blood pressure drops is arranged.
The object of the present invention is to provide a kind of medicine for the treatment of diabetes complicated coronary heart disease.Its function is that heart-nourishing and Qi-benefiting, blood sugar lowering degrease, blood stasis dispelling are promoted blood circulation, promoting the production of body fluid and inducing sedation of the mind, reach its not only blood sugar lowering but also treat the effect of diabetic complication coronary heart disease.
Medicine of the present invention be with FRUCTUS LYCII, Fructus Schisandrae Chinensis, Radix Salviae Miltiorrhizae,, Radix Ginseng, Radix Ophiopogonis be raw material, wherein FRUCTUS LYCII is a monarch drug, Fructus Schisandrae Chinensis, Radix Salviae Miltiorrhizae are ministerial drug, assistant is formulated with Radix Ginseng, Radix Ophiopogonis
Each raw materials in part by weight ratio is in the medicine of the present invention:
FRUCTUS LYCII 30-50 Fructus Schisandrae Chinensis 30-50 Radix Salviae Miltiorrhizae 25-45
Radix Ophiopogonis 20-40 Radix Ginseng 5-15
The formula optimization weight ratio for preparing each raw material of this medicine is:
FRUCTUS LYCII 40g, Fructus Schisandrae Chinensis 40g, Radix Salviae Miltiorrhizae 30g, Radix Ophiopogonis 30g, Radix Ginseng 10g
The method that above-mentioned each medicine is made medicine is: the FRUCTUS LYCII after will screening, Fructus Schisandrae Chinensis, Radix Salviae Miltiorrhizae, Radix Ophiopogonis, Radix Ginseng be the rinsing drying respectively, pulverizes behind the ultraviolet disinfection, with the sterilization again behind the mix homogeneously of putting together of each medicated powder, with drugs packaging, promptly gets this finished product.
Good effect of the present invention is: FRUCTUS LYCII has that multiple arteries and veins takes off admittedly, the effect of stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, the strengthening the spleen that nourishes heart, the effect that stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, heart-nourishing and Qi-benefiting are arranged after each medicine combination, respond well to diabetes complicated coronary heart disease, have no side effect, clinical employing Jiangtangwan pill adds this medicine and unites use, has that lung moistening clears away heart-fire, the effect of coronary dilating blood supply.It is excellent that diabetes and coronary heart disease is used curative effect than the other medicines compatibility.Relapse rate, the case fatality rate of primary disease are lowered.
Embodiment 1: the FRUCTUS LYCII 40g after will screening, Fructus Schisandrae Chinensis 40g, Radix Salviae Miltiorrhizae 30g, Radix Ophiopogonis, 30g, Radix Ginseng 10g carried out rinsing, drying respectively, pulverizing is 100-120 order medicated powder after carrying out disinfection by ultraviolet light, the sterilization again behind the mix homogeneously of then each medicine being put together, with the medicated powder packing, promptly get this finished product.
Embodiment 2: the FRUCTUS LYCII 30g after will screening, Fructus Schisandrae Chinensis 30g, Radix Salviae Miltiorrhizae 25g, Radix Ophiopogonis, 20g, Radix Ginseng 5g carried out rinsing, drying respectively, pulverizing is 100-120 order medicated powder after carrying out disinfection by ultraviolet light, the sterilization again behind the mix homogeneously of then each medicine being put together, with the medicated powder packing, promptly get this finished product.
Embodiment 3: the FRUCTUS LYCII 50g after will screening, Fructus Schisandrae Chinensis 50g, Radix Salviae Miltiorrhizae 45g, Radix Ophiopogonis, 40g, Radix Ginseng 15g carried out rinsing, drying respectively, pulverizing is 100-120 order medicated powder after carrying out disinfection by ultraviolet light, the sterilization again behind the mix homogeneously of then each medicine being put together, with the medicated powder packing, promptly get this finished product.
Claims (2)
1, a kind of medicine for the treatment of diabetes and coronary heart disease is characterized in that: the raw material of this medicine and raw materials in part by weight ratio be, FRUCTUS LYCII 30-50, Fructus Schisandrae Chinensis 30-50, Radix Salviae Miltiorrhizae 25-40, Radix Ophiopogonis 20-40, Radix Ginseng 5-15.
2, a kind of manufacture method for the treatment of the medicine of diabetes and coronary heart disease, it is characterized in that: FRUCTUS LYCII, Fructus Schisandrae Chinensis, Radix Salviae Miltiorrhizae, Radix Ophiopogonis, Radix Ginseng carry out rinsing, drying respectively after will screening, pulverizing is 100-120 order medicated powder after carrying out disinfection by ultraviolet light, the sterilization again behind the mix homogeneously of then each medicine being put together, with the medicated powder packing, promptly get this finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00123116 CN1183923C (en) | 2000-10-20 | 2000-10-20 | Medicine for treating diabetes and coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00123116 CN1183923C (en) | 2000-10-20 | 2000-10-20 | Medicine for treating diabetes and coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1349803A true CN1349803A (en) | 2002-05-22 |
| CN1183923C CN1183923C (en) | 2005-01-12 |
Family
ID=4589593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00123116 Expired - Fee Related CN1183923C (en) | 2000-10-20 | 2000-10-20 | Medicine for treating diabetes and coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1183923C (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526358A (en) * | 2012-02-13 | 2012-07-04 | 赵树刚 | Medicinal composition for treating diabetes and preparation method thereof |
| CN103239620A (en) * | 2013-04-27 | 2013-08-14 | 陈晖� | Traditional Chinese medicine for treating qi-deficiency heart diseases |
| CN104324205A (en) * | 2014-11-29 | 2015-02-04 | 张晨 | Traditional Chinese medicine composition for treating heart diseases |
| CN105497495A (en) * | 2015-12-21 | 2016-04-20 | 北京同仁堂科技发展股份有限公司 | Traditional Chinese medicine composition with anti-fatigue effect and preparation method and application thereof |
| CN105497496A (en) * | 2015-12-21 | 2016-04-20 | 北京同仁堂科技发展股份有限公司 | Traditional Chinese medicine composition with effect of improving male sexual functions and preparation method and application thereof |
| CN105535425A (en) * | 2015-12-21 | 2016-05-04 | 北京同仁堂科技发展股份有限公司 | A traditional Chinese medicine composition having an immunity boosting function, a preparing method thereof and uses of the composition |
| CN108126101A (en) * | 2018-03-05 | 2018-06-08 | 中国人民解放军第四军医大学 | It is a kind of to be used to treat pharmaceutical preparation of diabetic cardiomyopathy and preparation method thereof |
| CN116115690A (en) * | 2023-01-06 | 2023-05-16 | 石家庄市人民医院 | Traditional Chinese medicine composition for treating diabetes combined with non-alcoholic fatty liver |
-
2000
- 2000-10-20 CN CN 00123116 patent/CN1183923C/en not_active Expired - Fee Related
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526358A (en) * | 2012-02-13 | 2012-07-04 | 赵树刚 | Medicinal composition for treating diabetes and preparation method thereof |
| CN102526358B (en) * | 2012-02-13 | 2013-07-31 | 赵树刚 | Medicinal composition for treating diabetes and preparation method thereof |
| CN103239620A (en) * | 2013-04-27 | 2013-08-14 | 陈晖� | Traditional Chinese medicine for treating qi-deficiency heart diseases |
| CN103239620B (en) * | 2013-04-27 | 2014-12-10 | 陈晖� | Traditional Chinese medicine for treating qi-deficiency heart diseases |
| CN104324205A (en) * | 2014-11-29 | 2015-02-04 | 张晨 | Traditional Chinese medicine composition for treating heart diseases |
| CN105497496A (en) * | 2015-12-21 | 2016-04-20 | 北京同仁堂科技发展股份有限公司 | Traditional Chinese medicine composition with effect of improving male sexual functions and preparation method and application thereof |
| CN105497495A (en) * | 2015-12-21 | 2016-04-20 | 北京同仁堂科技发展股份有限公司 | Traditional Chinese medicine composition with anti-fatigue effect and preparation method and application thereof |
| CN105535425A (en) * | 2015-12-21 | 2016-05-04 | 北京同仁堂科技发展股份有限公司 | A traditional Chinese medicine composition having an immunity boosting function, a preparing method thereof and uses of the composition |
| CN105497496B (en) * | 2015-12-21 | 2019-01-15 | 北京同仁堂科技发展股份有限公司 | It is a kind of with Chinese medicine composition and preparation method thereof and purposes for improving male's sexual effect |
| CN105535425B (en) * | 2015-12-21 | 2019-05-31 | 北京同仁堂科技发展股份有限公司 | A kind of Chinese medicine composition with strengthen immunity effect and preparation method thereof and purposes |
| CN108126101A (en) * | 2018-03-05 | 2018-06-08 | 中国人民解放军第四军医大学 | It is a kind of to be used to treat pharmaceutical preparation of diabetic cardiomyopathy and preparation method thereof |
| CN116115690A (en) * | 2023-01-06 | 2023-05-16 | 石家庄市人民医院 | Traditional Chinese medicine composition for treating diabetes combined with non-alcoholic fatty liver |
| CN116115690B (en) * | 2023-01-06 | 2024-03-22 | 石家庄市人民医院 | Traditional Chinese medicine composition for treating diabetes combined with non-alcoholic fatty liver |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1183923C (en) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100435831C (en) | Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method | |
| CN1895620A (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN101129609A (en) | Chrysanthemum powder forimproving acuity of vision | |
| CN1183923C (en) | Medicine for treating diabetes and coronary heart disease | |
| CN1194724C (en) | Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof | |
| CN1056532C (en) | Blood pressure depressing Yongquan plaster | |
| CN1111054C (en) | Medicine for treating apoplexy and its preparing process | |
| CN101507810A (en) | Chinese patent medicine preparation capable of treating arrhythmia | |
| CN102475748A (en) | Fleeceflower root salvia tablet | |
| CN1326548C (en) | Medicine for treating gonorrhoea | |
| CN102266528B (en) | Medicament for treating hypertension | |
| CN1079263C (en) | Capsule for curing chronic enteritis | |
| CN1167458C (en) | Capsule (tablet) made from 5 pure Chinese medicinal plants for curing cardiovascular diseases, cerebrovascular disease and its preparation method | |
| CN101181424B (en) | Medicament for curing aberrat menses as well as preparation technique thereof | |
| CN1304771A (en) | Anshen pill-treating cardio-cerebral angiopathy | |
| CN1176685C (en) | Medicine for preventing and treating coronary heart disease and its prepn process | |
| CN101199742A (en) | Capsule of auxiliary treatment AIDS and preparing method thereof | |
| CN1151817C (en) | Fracture setting granule for treating bone injury and its prepn process | |
| CN102552395A (en) | Preparation method of compound red-rooted salvia root tablet | |
| CN1176710C (en) | Medicine for treating burn and scald and preparation method thereof | |
| CN104587392A (en) | Medicine for improving microcirculation | |
| CN1040724C (en) | Method to prepare speech-restoring pill | |
| CN1261155C (en) | Medication of Chinese traditional medicine for treating ischemia in blood vessel of heart and brain | |
| CN1515311A (en) | Blood-lipid-reducing thrombolytic medicine | |
| CN1251302A (en) | Traditional Chinese medicine of compounded chlorophyll for treating vegetative nervous disorder and its producing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |